Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection Of Lung Malignancies.

Recruiting
18 years - 99 years
All
Phase 2
40 participants needed
1 Location

Brief description of study

The purpose of this research study is to learn if the investigational study drug, pegsitacianine, helps in seeing the primary lung cancer tumor and identifying any additional cancerous tissue present in the lung for removal at the time of standard of care cancer surgery. Each participant will receive a single dose of pegsitacianine.

Detailed description of study

The purpose of this research study is to learn if the investigational study drug, pegsitacianine, helps in seeing the primary lung cancer tumor and identifying any additional cancerous tissue present in the lung for removal at the time of standard of care cancer surgery Each participant will receive a single dose of pegsitacianine.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research, Lung, Lung Malignancies, tumor, lung cancer
  • Age: 18 years - 99 years
  • Gender: All

Diagnosed with Lung Cancer

Updated on 04 Aug 2024. Study ID: 850299

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center